Respiration Disorders
Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
Subtype terms (16)
More specific conditions that are subtypes of Respiration Disorders in the MeSH hierarchy.
- Acute Chest Syndrome
12 drugs (11 approved, 1 experimental)
- Altitude Sickness
48 drugs (29 approved, 19 experimental)
- Apnea
22 drugs (20 approved, 2 experimental)
- Cheyne-Stokes Respiration
3 drugs (2 approved, 1 experimental)
- Cough
158 drugs (69 approved, 89 experimental)
- Dyspnea
48 drugs (34 approved, 14 experimental)
- Hoarseness
3 drugs (2 approved, 1 experimental)
- Hyperventilation
2 drugs approved
- Meconium Aspiration Syndrome
8 drugs (3 approved, 5 experimental)
- Mouth Breathing
2 drugs approved
- Respiratory Aspiration
28 drugs (25 approved, 3 experimental)
- Respiratory Distress Syndrome
225 drugs (123 approved, 102 experimental)
- Respiratory Insufficiency
121 drugs (98 approved, 23 experimental)
- Sarcoglycanopathies
1 drug experimental
- Tachypnea
3 drugs (2 approved, 1 experimental)
- Vocal Cord Dysfunction
17 drugs (12 approved, 5 experimental)
Drugs by status
Approved for this indication (3)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (16)
- AstraZeneca
- Serum Institute of India Pvt. Ltd.
- Boehringer Ingelheim
- United States Army
- United States Navy
- University of Tehran
- University of Zurich
- Icahn School of Medicine at Mount Sinai
- Medical University of Vienna
- Isfahan University
- University of New South Wales
- University of Western Ontario
- Rassoul Akram Hospital
- Yuhan Pharmaceutical Company
- Government of Kyrgyzstan
- Ross University School of Veterinary Medicine
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (18)
- Debiopharm
- Cumberland Pharmaceuticals
- Pulmocide Ltd
- Fundación Pública Andaluza
- Harvard University
- University of Rochester
- University of Seville
- University of Southern California
- Columbia University
- University of Cincinnati
- Food and Drug Administration
- Scripps
- University of Duesseldorf
- Clinipace LTD
- Novotech
- Government of Germany
- Beyond Air Ltd
- PureTech
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (18)
- Fundacion Infant
- Case Western Reserve University
- University of London
- Katholieke Universiteit Leuven
- University of Leeds
- University of Manchester
- University of Nottingham
- University of York
- Cardiff University
- University of California, San Francisco
- Université catholique de Louvain
- University of Applied Sciences of Western Switzerland
- School of Gestion and Engineering Vaud
- National Council of Scientific and Technical Research, Argentina
- Yorkshire Cancer Research
- Yedikule Training and Research Hospital
- Centro de Excelencia en Productos y Procesos Córdoba
- Química Luar SRL